Magnesium sulfate Alternatives Compared
| Magnesium sulfate | Lamictal (lamotrigine) | Lamotrigine |
|
|---|
| Magnesium sulfate | Lamictal (lamotrigine) | Lamotrigine |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription and OTC
Prescribed for Hypomagnesemia, Seizure Prevention, Ventricular Arrhythmia, Barium Poisoning. Magnesium sulfate may also be used for purposes not listed in this medication guide. |
Prescription only
Lamictal is used to decrease the frequency and severity of seizures in some types of epilepsy and also to stabilize mood in bipolar I disorder. It is an oral tablet that is taken once or twice a day... View more |
Prescription only
Lamotrigine is used to decrease the frequency and severity of seizures in some types of epilepsy and also to stabilize mood in bipolar I disorder. It is an oral tablet that is taken once or twice a... View more |
Related suggestions Seizure Prevention (Seizure Prophylaxis)
|
|||||||||||||||||||||||
| More about Magnesium sulfate | More about Lamictal (lamotrigine) | More about Lamotrigine | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Magnesium sulfate has an average rating of 7.0 out of 10 from a total of 6 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Lamictal has an average rating of 8.0 out of 10 from a total of 794 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 13% reported a negative effect. |
Lamotrigine has an average rating of 7.8 out of 10 from a total of 1841 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Magnesium sulfate side effects |
View all Lamictal side effects |
View all Lamotrigine side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Magnesium sulfate prices |
View all Lamictal prices |
View all Lamotrigine prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Epsom Salt | Other lamotrigine brands include: Lamictal CD, Lamictal ODT, Lamictal XR, Subvenite | Lamictal, Lamictal CD, Lamictal ODT, Lamictal XR, Subvenite | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
25.7 hours |
25.7 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 105 drugs are known to interact with Magnesium sulfate:
|
A total of 286 drugs are known to interact with Lamictal:
|
A total of 286 drugs are known to interact with Lamotrigine:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
December 27, 1994 |
December 27, 1994 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.